CERT - Certara Inc logo

CERT

Certara Inc

Certara Inc. provides biosimulation software and services to optimize drug discovery and development processes. Its clients include biopharmaceutical companies and regulatory agencies, utilizing tools for pharmacokinetics prediction, data automation, and regulatory submissions.

โš•๏ธ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago โ†’$275today

Score Overview

1 Year
Score
Net Growth-40x
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-2.48%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.6
Net Growth-415.63%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth42.76%
Rev Trend80%
Revenue Consistencyโ€”
All Time
Score
Net Growth-38.48%
Net Trend67%
Net Income Consistency
Rev Growth67.72%
Rev Trend83%
Revenue Consistency

See the full market ranking โ†’

Certara Inc fundamental performance

Across Certara Inc's full reported history, from 2020 to 2025, revenue grew from $ 243M to $ 418M and net income went from -$ 49M to -$ 1M. Revenue increased in 83% of the years measured; net income in 67%.

Certara Inc currently holds a 5-year HDB Score of 4.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 8.01โ€”
1 Year2025-08-12
$ 10.75-25.49%
5 Years2021-08-12
$ 29.17-72.54%
All Time2020-12-11
$ 38.08-78.97%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 408M-$ 68M$ 184M
2025$ 418M-$ 1M$ 189M
2024$ 385M-$ 12M$ 179M
2023$ 354M-$ 55M$ 234M
2022$ 335M$ 14M$ 236M
2021$ 286M-$ 13M$ 185M
IPO2020$ 243M-$ 49M$ 271M

Explore beyond CERT

You're looking at Certara Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies